119 related articles for article (PubMed ID: 26715063)
21. Ablation of epidermal RXRα in cooperation with activated CDK4 and oncogenic NRAS generates spontaneous and acute neonatal UVB induced malignant metastatic melanomas.
Chagani S; Wang R; Carpenter EL; Löhr CV; Ganguli-Indra G; Indra AK
BMC Cancer; 2017 Nov; 17(1):736. PubMed ID: 29121869
[TBL] [Abstract][Full Text] [Related]
22. Increased levels of β-catenin, LEF-1, and HPA-1 correlate with poor prognosis for acral melanoma with negative BRAF and NRAS mutation in BRAF exons 11 and 15 and NRAS exons 1 and 2.
Xu S; Yang Z; Zhang J; Jiang Y; Chen Y; Li H; Liu X; Xu D; Chen Y; Yang Y; Zhang Y; Li D; Xia J
DNA Cell Biol; 2015 Jan; 34(1):69-77. PubMed ID: 25343173
[TBL] [Abstract][Full Text] [Related]
23. A Murine Model for Metastatic Conjunctival Melanoma.
de Waard NE; Cao J; McGuire SP; Kolovou PE; Jordanova ES; Ksander BR; Jager MJ
Invest Ophthalmol Vis Sci; 2015 Apr; 56(4):2325-33. PubMed ID: 25722211
[TBL] [Abstract][Full Text] [Related]
24. Neuroblastoma RAS viral oncogene homolog mRNA is differentially spliced to give five distinct isoforms: implications for melanoma therapy.
Duggan MC; Regan-Fendt K; Olaverria Salavaggione GN; Howard JH; Stiff AR; Sabella J; Latchana N; Markowitz J; Gru A; Tridandapani S; Eisfeld AK; de la Chapelle A; Carson WE
Melanoma Res; 2019 Oct; 29(5):491-500. PubMed ID: 31116161
[TBL] [Abstract][Full Text] [Related]
25. Intra-patient Heterogeneity of BRAF and NRAS Molecular Alterations in Primary Melanoma and Metastases.
Pellegrini C; Cardelli L; Padova M; Nardo LD; Ciciarelli V; Rocco T; Cipolloni G; Clementi M; Cortellini A; Ventura A; Leocata P; Fargnoli MC
Acta Derm Venereol; 2020 Jan; 100(1):adv00040. PubMed ID: 31774543
[TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of BRAF and NRAS mutations in melanoma: a German study from routine care.
Heppt MV; Siepmann T; Engel J; Schubert-Fritschle G; Eckel R; Mirlach L; Kirchner T; Jung A; Gesierich A; Ruzicka T; Flaig MJ; Berking C
BMC Cancer; 2017 Aug; 17(1):536. PubMed ID: 28797232
[TBL] [Abstract][Full Text] [Related]
27. High specificity and sensitivity of NRAS Q61R immunohistochemistry (IHC) in melanomas.
Just PA; Pouliquen C; Audebourg A; Laurent-Roussel S; Carlotti A; Dupin N; Vacher-Lavenu MC; Vidaud M; Terris B; Pasmant E
J Am Acad Dermatol; 2016 Mar; 74(3):572-3. PubMed ID: 26892658
[No Abstract] [Full Text] [Related]
28. NRAS (Q61R), BRAF (V600E) immunohistochemistry: a concomitant tool for mutation screening in melanomas.
Uguen A; Talagas M; Costa S; Samaison L; Paule L; Alavi Z; De Braekeleer M; Le Marechal C; Marcorelles P
Diagn Pathol; 2015 Jul; 10():121. PubMed ID: 26204954
[TBL] [Abstract][Full Text] [Related]
29. [Signal transduction in melanoma].
Yokoyama S
Seikagaku; 2013 Jun; 85(6):469-74. PubMed ID: 23875475
[No Abstract] [Full Text] [Related]
30. Concordance of somatic mutation profiles (BRAF,NRAS, and TERT) and tumoral PD-L1 in matched primary cutaneous and metastatic melanoma samples.
Yang S; Leone DA; Biswas A; Deng A; Jukic D; Singh R; Sundram U; Mahalingam M
Hum Pathol; 2018 Dec; 82():206-214. PubMed ID: 30120967
[TBL] [Abstract][Full Text] [Related]
31. Pharmacological Targeting of STK19 Inhibits Oncogenic NRAS-Driven Melanomagenesis.
Yin C; Zhu B; Zhang T; Liu T; Chen S; Liu Y; Li X; Miao X; Li S; Mi X; Zhang J; Li L; Wei G; Xu ZX; Gao X; Huang C; Wei Z; Goding CR; Wang P; Deng X; Cui R
Cell; 2019 Feb; 176(5):1113-1127.e16. PubMed ID: 30712867
[TBL] [Abstract][Full Text] [Related]
32. Association between BRAFV600E and NRASQ61R mutations and clinicopathologic characteristics, risk factors and clinical outcome of primary invasive cutaneous melanoma.
Wu S; Kuo H; Li WQ; Canales AL; Han J; Qureshi AA
Cancer Causes Control; 2014 Oct; 25(10):1379-86. PubMed ID: 25048604
[TBL] [Abstract][Full Text] [Related]
33. MIG6 Is MEK Regulated and Affects EGF-Induced Migration in Mutant NRAS Melanoma.
Vu HL; Rosenbaum S; Capparelli C; Purwin TJ; Davies MA; Berger AC; Aplin AE
J Invest Dermatol; 2016 Feb; 136(2):453-463. PubMed ID: 26967478
[TBL] [Abstract][Full Text] [Related]
34. Activity of the heat shock protein 90 inhibitor ganetespib in melanoma.
Wu X; Marmarelis ME; Hodi FS
PLoS One; 2013; 8(2):e56134. PubMed ID: 23418523
[TBL] [Abstract][Full Text] [Related]
35. Expression of MCSP and PRAME in conjunctival melanoma.
Westekemper H; Karimi S; Süsskind D; Anastassiou G; Freistühler M; Meller D; Zeschnigk M; Steuhl KP; Bornfeld N; Schmid KW; Grabellus F
Br J Ophthalmol; 2010 Oct; 94(10):1322-7. PubMed ID: 20805128
[TBL] [Abstract][Full Text] [Related]
36. Expression of AP-2α, AP-2γ and ESDN in primary melanomas: correlation with histopathological features and potential prognostic value.
Osella-Abate S; Novelli M; Quaglino P; Orso F; Ubezio B; Tomasini C; Berardengo E; Bernengo MG; Taverna D
J Dermatol Sci; 2012 Dec; 68(3):202-4. PubMed ID: 23036739
[No Abstract] [Full Text] [Related]
37. MEK inhibition may increase survival of NRAS-mutated melanoma patients treated with checkpoint blockade: Results of a retrospective multicentre analysis of 364 patients.
Kirchberger MC; Ugurel S; Mangana J; Heppt MV; Eigentler TK; Berking C; Schadendorf D; Schuler G; Dummer R; Heinzerling L
Eur J Cancer; 2018 Jul; 98():10-16. PubMed ID: 29843107
[TBL] [Abstract][Full Text] [Related]
38. NRASQ61R Mutation-specific Immunohistochemistry Also Identifies the HRASQ61R Mutation in Medullary Thyroid Cancer and May Have a Role in Triaging Genetic Testing for MEN2.
Reagh J; Bullock M; Andrici J; Turchini J; Sioson L; Clarkson A; Watson N; Sheen A; Lim G; Delbridge L; Sidhu S; Sywak M; Aniss A; Shepherd P; Ng D; Oei P; Field M; Learoyd D; Robinson BG; Clifton-Bligh RJ; Gill AJ
Am J Surg Pathol; 2017 Jan; 41(1):75-81. PubMed ID: 27635947
[TBL] [Abstract][Full Text] [Related]
39. Metabolic rewiring in melanoma.
Ratnikov BI; Scott DA; Osterman AL; Smith JW; Ronai ZA
Oncogene; 2017 Jan; 36(2):147-157. PubMed ID: 27270434
[TBL] [Abstract][Full Text] [Related]
40. Molecular analysis of atypical deep penetrating nevus progressing to melanoma.
Isales MC; Khan AU; Zhang B; Compres EV; Kim D; Tan TL; Beaubier N; Gerami P
J Cutan Pathol; 2020 Dec; 47(12):1150-1154. PubMed ID: 32526042
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
